Kestra Medical Technologies Secures $200M Loan Facility

Kirkland-based Kestra Medical Technologies secured up to $200M in non-dilutive financing managed by Pharmakon Advisors, LP. The funding will support continued growth and help advance the company’s Assure wearable cardioverter defibrillator, which provides autonomous detection and defibrillation for ventricular arrhythmias.